NeuBase Therapeutics Cash from Investing (TTM) Analysis

NeuBase Therapeutics Inc (NBSE)

0.4121 0.00 (0.00%) USD | NASDAQ | May 02, 16:00

0.4121 0.00 (0.00%) After-Hours: 16:05

Cash from Investing (TTM) Chart

Historical Cash from Investing (TTM) Data

View and export this data back to 2004. Upgrade now.

Date	Value
September 30, 2023	-0.0548M
June 30, 2023	-0.0836M
March 31, 2023	-0.2542M
December 31, 2022	-0.3977M
September 30, 2022	-0.4717M
June 30, 2022	-0.7946M
March 31, 2022	-2.418M
December 31, 2021	-2.479M
September 30, 2021	-2.564M
June 30, 2021	-2.566M
March 31, 2021	-0.9728M
December 31, 2020	-0.857M
September 30, 2020	-0.7168M
June 30, 2020	-1.044M
March 31, 2020	-0.8431M
December 31, 2019	-0.7536M
September 30, 2019
June 30, 2019
March 31, 2019
December 31, 2018
September 30, 2018
June 30, 2018
March 31, 2018
December 31, 2017
September 30, 2017	0.0885M

Date	Value
June 30, 2017	0.0822M
March 31, 2017	-0.0072M
December 31, 2016	-0.0088M
September 30, 2016	-0.0145M
June 30, 2016	-0.0154M
March 31, 2016	-0.1102M
December 31, 2015	-0.2955M
September 30, 2015	-0.285M
June 30, 2015	-0.2977M
March 31, 2015	-3.702M
December 31, 2014	-3.515M
September 30, 2014	-3.515M
June 30, 2014	-3.50M
March 31, 2014	0.00
December 31, 2013	0.00
September 30, 2013	0.00
June 30, 2013	0.00
March 31, 2013	0.00
December 31, 2012	0.00
September 30, 2012	-0.0334M
June 30, 2012	-0.0334M
March 31, 2012	-0.0334M
December 31, 2011	0.0371M
September 30, 2011	0.0705M
June 30, 2011	0.0455M

Cash From Investing Definition

Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.

Read full definition.

Cash from Investing (TTM) Range, Past 5 Years

-2.566M

Minimum

Jun 2021

-0.0548M

Maximum

Sep 2023

-1.079M

Average

-0.8188M

Median

Cash from Investing (TTM) Benchmarks